www.linkedin.com Open in urlscan Pro
2620:1ec:21::14  Public Scan

Form analysis
2 forms found in the DOM

POST https://www.linkedin.com/uas/login-submit

<form class="google-auth" action="https://www.linkedin.com/uas/login-submit" method="post" aria-hidden="true">
  <input name="loginCsrfParam" value="bb985448-ac16-4b9b-8992-8dd88ce9d9de" type="hidden">
  <input name="session_redirect" value="https://www.linkedin.com/company/biopharmaapac-news" type="hidden">
  <input name="trk" value="organization_guest_google-one-tap-submit" type="hidden">
  <code id="termsAndConditionsRendered" style="display: none"><!--true--></code>
  <div class="google-one-tap__module hidden fixed flex flex-col items-center top-[20px] right-[20px] z-[9999]">
    <div class="relative top-2 bg-color-background-container-tint pl-2 pr-1 pt-2 pb-3 w-[375px] rounded-md shadow-2xl">
      <p class="text-md font-bold text-color-text"> Zustimmen und LinkedIn beitreten </p>
      <p class="text-sm text-color-text" data-impression-id="organization_guest_one-tap-skip-tc-text"> Durch Klicken auf „Weiter“ stimmen Sie der
        <a href="/legal/user-agreement?trk=organization_guest_google-auth-button_user-agreement" target="_blank" data-tracking-control-name="organization_guest_google-auth-button_user-agreement" data-tracking-will-navigate="true">Nutzervereinbarung</a>,
        der
        <a href="/legal/privacy-policy?trk=organization_guest_google-auth-button_privacy-policy" target="_blank" data-tracking-control-name="organization_guest_google-auth-button_privacy-policy" data-tracking-will-navigate="true">Datenschutzrichtlinie</a>
        und der
        <a href="/legal/cookie-policy?trk=organization_guest_google-auth-button_cookie-policy" target="_blank" data-tracking-control-name="organization_guest_google-auth-button_cookie-policy" data-tracking-will-navigate="true">Cookie-Richtlinie</a>
        von LinkedIn zu. </p>
    </div>
    <div data-tracking-control-name="organization_guest_google-one-tap" id="google-one-tap__container"></div>
  </div>
  <div class="loader loader--full-screen">
    <div class="loader__container mb-2 overflow-hidden">
      <icon class="loader__icon inline-block loader__icon--default text-color-progress-loading lazy-loaded" data-svg-class-name="loader__icon-svg--large fill-currentColor h-[60px] min-h-[60px] w-[60px] min-w-[60px]" aria-hidden="true"
        aria-busy="false"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 60 60" width="60" height="60" focusable="false" class="loader__icon-svg--large fill-currentColor h-[60px] min-h-[60px] w-[60px] min-w-[60px] lazy-loaded"
          aria-busy="false">
          <g>
            <path opacity="1" d="M30.1,16.1L30.1,16.1c-0.6,0-1-0.5-1-1V1c0-0.6,0.5-1,1-1l0,0c0.6,0,1,0.5,1,1v14.1C31.1,15.7,30.6,16.1,30.1,16.1z"></path>
            <path opacity="0.85" d="M23.1,18.1L23.1,18.1c-0.5,0.3-1.1,0.1-1.4-0.4L14.5,5.6c-0.3-0.5-0.2-1.1,0.4-1.4l0,0C15.4,3.9,16,4,16.3,4.6l7.2,12.1C23.8,17.2,23.6,17.8,23.1,18.1z"></path>
            <path opacity="0.77" d="M17.9,23.1L17.9,23.1c-0.3,0.5-0.9,0.7-1.4,0.4l-12.2-7c-0.5-0.3-0.7-0.9-0.4-1.4l0,0c0.3-0.5,0.9-0.7,1.4-0.4l12.2,7C18,22,18.2,22.7,17.9,23.1z"></path>
            <path opacity="0.69" d="M16.1,30.1L16.1,30.1c0,0.6-0.5,1-1,1L1,31.2c-0.6,0-1-0.5-1-1l0,0c0-0.6,0.5-1,1-1l14.1-0.1C15.7,29.1,16.1,29.5,16.1,30.1z"></path>
            <path opacity="0.61" d="M18,36.9L18,36.9c0.3,0.5,0.2,1.1-0.4,1.4L5.5,45.6c-0.5,0.3-1.1,0.2-1.4-0.4l0,0c-0.3-0.5-0.2-1.1,0.4-1.4l12.1-7.3C17.1,36.2,17.7,36.4,18,36.9z"></path>
            <path opacity="0.53" d="M23.3,42.1L23.3,42.1c0.5,0.3,0.6,0.9,0.4,1.4l-7.3,12.1c-0.3,0.5-0.9,0.6-1.4,0.4l0,0c-0.5-0.3-0.6-0.9-0.4-1.4l7.3-12.1C22.1,41.9,22.8,41.8,23.3,42.1z"></path>
            <path opacity="0.45" d="M30.1,43.9L30.1,43.9c0.6,0,1,0.5,1,1V59c0,0.6-0.5,1-1,1l0,0c-0.6,0-1-0.5-1-1V44.9C29,44.4,29.5,43.9,30.1,43.9z"></path>
            <path opacity="0.37" d="M37,41.9L37,41.9c0.5-0.3,1.1-0.2,1.4,0.4l7.2,12.1c0.3,0.5,0.2,1.1-0.4,1.4l0,0c-0.5,0.3-1.1,0.2-1.4-0.4l-7.2-12.1C36.4,42.8,36.6,42.2,37,41.9z"></path>
            <path opacity="0.29" d="M42.2,36.8L42.2,36.8c0.3-0.5,0.9-0.7,1.4-0.4l12.2,7c0.5,0.3,0.7,0.9,0.4,1.4l0,0c-0.3,0.5-0.9,0.7-1.4,0.4l-12.2-7C42.1,38,41.9,37.4,42.2,36.8z"></path>
            <path opacity="0.21 " d="M44,29.9L44,29.9c0-0.6,0.5-1,1-1h14.1c0.6,0,1,0.5,1,1l0,0c0,0.6-0.5,1-1,1L45,31C44.4,31,44,30.5,44,29.9z"></path>
            <path opacity="0.13" d="M42.1,23.1L42.1,23.1c-0.3-0.5-0.2-1.1,0.4-1.4l12.1-7.3c0.5-0.3,1.1-0.2,1.4,0.4l0,0c0.3,0.4,0.1,1.1-0.4,1.3l-12.1,7.3C43.1,23.7,42.4,23.6,42.1,23.1z"></path>
            <path opacity="0.05" d="M36.9,17.9L36.9,17.9c-0.5-0.3-0.6-0.9-0.4-1.4l7.3-12.1c0.3-0.5,0.9-0.6,1.4-0.4l0,0c0.5,0.3,0.6,0.9,0.4,1.4l-7.4,12.2C38,18.1,37.3,18.2,36.9,17.9z"></path>
            <animateTransform attributeName="transform" attributeType="XML" type="rotate" begin="0s" dur="1s" repeatCount="indefinite" calcMode="discrete" keyTimes="0;.0833;.166;.25;.3333;.4166;.5;.5833;.6666;.75;.8333;.9166;1"
              values="0,30,30;30,30,30;60,30,30;90,30,30;120,30,30;150,30,30;180,30,30;210,30,30;240,30,30;270,30,30;300,30,30;330,30,30;360,30,30"></animateTransform>
          </g>
        </svg></icon>
    </div>
  </div>
</form>

POST https://www.linkedin.com/uas/login-submit

<form data-id="sign-in-form" action="https://www.linkedin.com/uas/login-submit" method="post" novalidate="" class="mt-1.5 mb-2">
  <input name="loginCsrfParam" value="bb985448-ac16-4b9b-8992-8dd88ce9d9de" type="hidden">
  <div class="flex flex-col">
    <div class="mt-1.5" data-js-module-id="guest-input">
      <div class="flex flex-col">
        <label class="input-label mb-1" for="organization_guest_contextual-sign-in_sign-in-modal_session_key"> E-Mail-Adresse/Telefon </label>
        <div class="text-input flex">
          <input class="text-color-text font-sans text-md outline-0 bg-color-transparent grow" autocomplete="username" id="organization_guest_contextual-sign-in_sign-in-modal_session_key" name="session_key" required=""
            data-tracking-control-name="organization_guest_contextual-sign-in-modal_sign-in-modal_sign-in-session-key" data-tracking-client-ingraph="" type="text">
        </div>
      </div>
      <p class="input-helper mt-1.5" for="organization_guest_contextual-sign-in_sign-in-modal_session_key" role="alert" data-js-module-id="guest-input__message"></p>
    </div>
    <div class="mt-1.5" data-js-module-id="guest-input">
      <div class="flex flex-col">
        <label class="input-label mb-1" for="organization_guest_contextual-sign-in_sign-in-modal_session_password"> Passwort </label>
        <div class="text-input flex">
          <input class="text-color-text font-sans text-md outline-0 bg-color-transparent grow" autocomplete="current-password" id="organization_guest_contextual-sign-in_sign-in-modal_session_password" name="session_password" required=""
            data-tracking-control-name="organization_guest_contextual-sign-in-modal_sign-in-modal_sign-in-password" data-tracking-client-ingraph="" type="password">
          <button aria-live="assertive" aria-relevant="text" data-id="sign-in-form__password-visibility-toggle" class="font-sans text-md font-bold text-color-action z-10 ml-[12px] hover:cursor-pointer" aria-label="LinkedIn Passwort einblenden"
            data-tracking-control-name="organization_guest_contextual-sign-in-modal_sign-in-modal_sign-in-password-visibility-toggle-btn" type="button">Einblenden</button>
        </div>
      </div>
      <p class="input-helper mt-1.5" for="organization_guest_contextual-sign-in_sign-in-modal_session_password" role="alert" data-js-module-id="guest-input__message"></p>
    </div>
    <input name="session_redirect" value="https://www.linkedin.com/company/biopharmaapac-news" type="hidden">
    <!---->
  </div>
  <div data-id="sign-in-form__footer" class="flex justify-between
          sign-in-form__footer--full-width">
    <a data-id="sign-in-form__forgot-password" class="font-sans text-md font-bold link leading-regular
            sign-in-form__forgot-password--full-width" href="https://www.linkedin.com/uas/request-password-reset?trk=organization_guest_contextual-sign-in-modal_sign-in-modal_forgot_password" data-tracking-control-name="organization_guest_contextual-sign-in-modal_sign-in-modal_forgot_password" data-tracking-will-navigate="">Passwort vergessen?</a>
    <!---->
    <input name="trk" value="organization_guest_contextual-sign-in-modal_sign-in-modal_sign-in-submit" type="hidden">
    <button class="btn-md btn-primary flex-shrink-0 cursor-pointer
            sign-in-form__submit-btn--full-width" data-id="sign-in-form__submit-btn" data-tracking-control-name="organization_guest_contextual-sign-in-modal_sign-in-modal_sign-in-submit-btn" data-tracking-client-ingraph="" data-tracking-litms=""
      type="submit"> Einloggen </button>
  </div>
  <div class="sign-in-form__divider left-right-divider pt-2 pb-3">
    <p class="sign-in-form__divider-text font-sans text-sm text-color-text px-2"> oder </p>
  </div>
  <input type="hidden" name="controlId" value="d_org_guest_company_overview-organization_guest_contextual-sign-in-modal_sign-in-modal_sign-in-submit-btn"><input type="hidden" name="pageInstance"
    value="urn:li:page:d_org_guest_company_overview_jsbeacon;YBEOvBS3TgqbQIr5NHTkeg==">
</form>

Text Content

LinkedIn und Drittanbieter setzen essenzielle und nicht zwingend erforderliche
Cookies ein, um die LinkedIn Dienste bereitzustellen, zu schützen, zu
analysieren und zu verbessern und um auf LinkedIn und außerhalb von LinkedIn
relevante Anzeigen zu präsentieren (einschließlich zielgruppenspezifischer
Anzeigen und Stellenanzeigen). Weitere Informationen finden Sie in unserer
Cookie-Richtlinie.

Wählen Sie „Akzeptieren“, um dieser Nutzung zuzustimmen, oder wählen Sie
„Ablehnen“, um die nicht zwingend erforderlichen Cookies abzulehnen. Sie können
Ihre Auswahl jederzeit in den Einstellungen aktualisieren.

Akzeptieren Ablehnen

Weiter zum Hauptinhalt
LinkedIn
 * Artikel
 * Personen
 * E-Learning
 * Jobs
 * App laden

Mitglied werden Einloggen


BIOPHARMA APAC


MEDIENPRODUKTION


PORT ROYAL, SOUTH CAROLINA 4.330 FOLLOWER:INNEN

ACCESS TO GLOBAL LIFESCIENCE , PHARMA , BIOPHARMA & HEALTH SCIENCE INDUSTRY

Folgen
   
 * 
   alle 13 Mitarbeiter:innen anzeigen
   

 * Dieses Unternehmen melden
   


INFO

BioPharma APAC provides a 360-degree view of the LifeScience and Health Science
market, spanning everything from investment, incubation and innovation, to
ingredients, food science and product formulation, labelling, litigation,
regulation, consumer trends, new products and new technology. Our content
standards are unsurpassed and we deliver insightful editorial, news, features
across multiple channels to the right people wherever they are in the business
of lifescience and healthscience

Website https://www.biopharmaapac.com

Externer Link zu BioPharma APAC

Branche Medienproduktion
Größe 51–200 Beschäftigte
Hauptsitz Port Royal, South Carolina
Art Selbständig
Gegründet 2015
Spezialgebiete Healthcare, Lifesciences, BioPharma, Pharma, Medtech, Diagnostic,
Consumerhealth, Clincal Research und Digital Health


ORTE

 * Primär
   
   Korea St
   
   Port Royal, South Carolina 29902, US
   
   Wegbeschreibung


BESCHÄFTIGTE VON BIOPHARMA APAC


 * SHERILYN TAN
   
   DEPUTY DIRECTOR AT SINGAPORE FOOD AGENCY


 * IZAAN ISTIJAB
   
   SCIENTIST AT NATIONAL PARKS BOARD


 * WAI-SENG YONG
   
   SENIOR AVA OFFICER AT AGRI-FOOD & VETERINARY AUTHORITY OF SINGAPORE

Alle Beschäftigten anzeigen


UPDATES

 * BioPharma APAC
   
   4.330 Follower:innen
   
   2 Std. Bearbeitet
    * Diesen Beitrag melden
      
   
   BioPharma APAC sits down with Glen Godresse, the newly appointed Chief
   Executive Officer of Menarini Asia-Pacific, to discuss his strategic vision
   for the company's future. With over 25 years of experience in the
   pharmaceutical industry and a personal drive influenced by his late mother's
   battle with cancer, Godresse is poised to steer Menarini Asia-Pacific towards
   addressing unmet patient needs through innovative R&D, partnerships, and a
   patient-first approach. Amid challenges and opportunities in the dynamic APAC
   region, Godresse outlines his plans for leveraging digital transformation,
   expanding market access, and prioritizing investments in niche therapy areas
   and anti-infectives to combat the growing threat of antimicrobial resistance.
   Under his leadership, Menarini Asia-Pacific aims to continue its legacy of
   growth and impact, fulfilling its commitment to health and life.
   https://lnkd.in/dk-YxY26
   
   
   GLEN GODRESSE CHARTS A NEW COURSE FOR MENARINI ASIA-PACIFIC: A VISION OF
   GROWTH THROUGH PATIENT-CENTRIC INNOVATION
   
   BIOPHARMAAPAC.COM
   
   Gefällt mir Kommentieren Teilen
 * BioPharma APAC
   
   4.330 Follower:innen
   
   3 Std. Bearbeitet
    * Diesen Beitrag melden
      
   
   Sherry Shao, GenScript's rotating CEO, said, "Despite market challenges in
   2023, the Group achieved 34.2% revenue growth and a five-year CAGR of 30%.
   This achievement was made possible by continuing to create value for our
   customers through high-impact innovation and our dedicated global team".
   
   
   GENSCRIPT SURGES WITH 34.2% REVENUE GROWTH IN 2023, SHERRY SHAO HIGHLIGHTS
   INNOVATION AND TEAM EFFORT
   
   BIOPHARMAAPAC.COM
   
   Gefällt mir Kommentieren Teilen
 * BioPharma APAC
   
   4.330 Follower:innen
   
   1 Tag
    * Diesen Beitrag melden
      
   
     Steve Hull, Chairman of Aptamer Group, said: “We are delighted to support
   our partners at @Unilever with Optimer technology that is providing novel
   solutions in multiple areas, now including fast-moving consumer goods. Over
   the past two years, we have worked closely with the team at Unilever, to
   develop successful binders and are pleased to see the promising results the
   binders are delivering in their laboratories, further validating our
   technology and leadership position in the affinity ligand market. With such
   strong results and the continued progression of this partnership, we are
   pleased to begin patenting these binders and allow the next stage of
   advances. I look forward to updating you on this project as it develops.”  
   
   
   APTAMER GROUP AND UNILEVER STRENGTHEN TIES WITH OPTIMER® DEVELOPMENT FOR
   CONSUMER GOODS
   
   BIOPHARMAAPAC.COM
   
   35 1 Kommentar
   Gefällt mir Kommentieren Teilen
 * BioPharma APAC
   
   4.330 Follower:innen
   
   2 Tage
    * Diesen Beitrag melden
      
   
   “Researchers and health care professionals have made great advances with the
   therapy and control of comorbidities of GPP and look forward to progressing
   those advances further as we continue to learn about this devastating
   disease,” said Karen Kaucic, M.D., president, patient and advisory services,
   and chief medical officer, PPD Clinical Research Units business, Thermo
   Fisher Scientific. “The @CorEvitas GPP registry will allow the prospective
   evaluation of GPP patients over many years, elucidating the natural history
   of the disease, paradigms of treatment and our ability to evaluate the impact
   of therapies to normalize quality of life and health outcomes of patients.”
   
   
   THERMO FISHER SCIENTIFIC LAUNCHES PIONEERING REGISTRY FOR GENERALIZED
   PUSTULAR PSORIASIS RESEARCH
   
   BIOPHARMAAPAC.COM
   
   Gefällt mir Kommentieren Teilen
 * BioPharma APAC
   
   4.330 Follower:innen
   
   2 Tage
    * Diesen Beitrag melden
      
   
   NanoString Technologies, Inc.'s President & CEO, Brad Gray, remarked, "This
   agreement with Patient Square Capital ensures our scientific community and
   workforce remain supported, marking a critical stride in our financial
   restructuring efforts." He further expressed confidence in Patient Square's
   commitment to NanoString’s vision to 'Map the Universe of Biology', backed by
   a readiness to nurture the company’s market-leading product pipeline.
   
   
   PATIENT SQUARE CAPITAL TO ACQUIRE NANOSTRING TECHNOLOGIES IN $220 MILLION
   DEAL AMID BANKRUPTCY PROCEEDINGS
   
   BIOPHARMAAPAC.COM
   
   2
   Gefällt mir Kommentieren Teilen
 * BioPharma APAC
   
   4.330 Follower:innen
   
   5 Tage
    * Diesen Beitrag melden
      
   
   “We’re pleased to welcome Ambrx’s talented scientific team and proprietary
   ADC platform to Johnson & Johnson. We look forward to continuing the
   development of ARX517, which represents a potential first- and best-in-class
   PSMA-targeting ADC for the treatment of metastatic castration-resistant
   prostate cancer,” said Yusri Elsayed, MD, MHSc,PhD, Global Therapeutic Area
   Head, Oncology, Johnson & Johnson Innovative Medicine.
   
   
   JOHNSON & JOHNSON COMPLETES $2 BILLION ACQUISITION OF AMBRX BIOPHARMA,
   BOLSTERING ONCOLOGY PIPELINE
   
   BIOPHARMAAPAC.COM
   
   Gefällt mir Kommentieren Teilen
 * BioPharma APAC
   
   4.330 Follower:innen
   
   5 Tage
    * Diesen Beitrag melden
      
   
   As we honor #internationalwomensday2024 , let's spotlight the remarkable
   women leading the revolution in the #Biopharma industry. From groundbreaking
   research to innovative leadership, these visionaries are setting new
   standards of excellence and inspiring a new generation of female leaders in
   science and business. Belén Garijo Merck Group Eva van Pelt QIAGEN Ruth
   Kuguru Novartis Laura Matz Yeoh Ying Ying Roche Hong Chow Serene Chang Neeta
   Singal Molecule AI KnowDis Sara Bresee MasterControl Lisa Britt Thermo Fisher
   Scientific Emily Leproust Twist Bioscience Dr. Yvonne Greenstreet Alnylam
   Pharmaceuticals Deborah Dunsire Lundbeck Reshma Kewalramani, MD FASN Vertex
   Pharmaceuticals Anne Wojcicki 23andMe Britt Meelby Jensen Helen Sabzevari
   Emma Walmsley GSK Kiran Mazumdar Shaw Biocon Biologics @Vinita Gupta Lupin
   Nandini Piramal Piramal Pharma Ltd Holly Rockweiler Nina Tandon, PhD/MBA
   
   
   VISIONARY TITANS: THE FEMALE FORCE REDEFINING THE BIOPHARMA INDUSTRY
   
   BIOPHARMAAPAC.COM
   
   14 1 Kommentar
   Gefällt mir Kommentieren Teilen
 * BioPharma APAC
   
   4.330 Follower:innen
   
   6 Tage
    * Diesen Beitrag melden
      
   
   Thomas Keller, speaking on the occasion, highlighted the importance of this
   new establishment in driving regional growth. "Our new Bangkok office is a
   testament to Eppendorf 's commitment to the Asia Pacific region. It serves as
   a hub for innovation, collaboration, and customer engagement, offering an
   excellent opportunity for our team and partners to interact directly with our
   customers," said Keller.
   
   
   EPPENDORF EXPANDS PRESENCE IN ASIA PACIFIC WITH NEW BANGKOK OFFICE
   
   BIOPHARMAAPAC.COM
   
   164 2 Kommentare
   Gefällt mir Kommentieren Teilen
 * BioPharma APAC
   
   4.330 Follower:innen
   
   6 Tage
    * Diesen Beitrag melden
      
   
   #MedicalFairIndia2024 is next week! Visit Oliver Healthcare Packaging at
   booth C11 to find out how our sterile flexible packaging solutions are
   tackling the key challenges today – from designing safe and compliant
   #medicalpackaging to mindful material selection. We can’t wait to see you
   there. #Medicalpackaging #Sustainabilty #FlexiblePackaging #SterilePackaging
   #PharmaceuticalPackaging #BarrierFilms
   #SustainablePackaging##qualityassurance #regulatorycompliance Schedule an
   appointment: https://lnkd.in/d7USEVAb?
   
    * 
   
   3
   Gefällt mir Kommentieren Teilen
 * BioPharma APAC
   
   4.330 Follower:innen
   
   6 Tage
    * Diesen Beitrag melden
      
   
   Sponsorship and partnership opportunities are open and available at
   LogiPharma Asia 2024. For more information, please
   contact sgwbrinfo@wbresearch.com To learn more about the
   conference: https://lnkd.in/gxS4KnCx
   
   
   LOGIPHARMA ASIA IS BACK FOR ITS 3RD EDITION THIS JUNE 2024
   
   BIOPHARMAAPAC.COM
   
   2
   Gefällt mir Kommentieren Teilen





EINFACH ANMELDEN, DAMIT SIE NICHTS VERPASSEN.

 * 
   Personen von BioPharma APAC finden, die Sie kennen
 * 
   Persönliche Jobempfehlungen erhalten
 * 
   Alle Updates, News und Artikel anzeigen

Jetzt anmelden


ÄHNLICHE SEITEN


 * CYTIVA
   
   Biotechnologieforschung
   
   Global, Global


 * THERMO FISHER SCIENTIFIC
   
   Biotechnologieforschung
   
   Waltham, MA


 * EPPENDORF
   
   Biotechnologieforschung


 * ROCHE
   
   Biotechnologieforschung


 * MERCK GRUPPE
   
   Arzneimittelherstellung


 * HILLEMAN LABORATORIES
   
   Forschungsdienstleistungen


 * ZUELLIG PHARMA
   
   Arzneimittelherstellung
   
   Singapore, Singapore


 * MODERNA
   
   Biotechnologieforschung
   
   Cambridge, Massachusetts


 * BIOGEN
   
   Biotechnologieforschung
   
   Cambridge, MA


 * ATAL INCUBATION CENTRE - CCMB
   
   Biotechnologie
   
   Hyderabad, Telangana

Mehr ähnliche Seiten anzeigen Weniger ähnliche Seiten anzeigen


JOBS DURCHSUCHEN


 * VERTRIEBSINGENIEUR-JOBS
   
   113.900 freie Stellen


 * KLINISCHER DATENMANAGER-JOBS
   
   10.204 freie Stellen


 * MITARBEITER FÜR KLINISCHE STUDIEN-JOBS
   
   6.711 freie Stellen


 * PERSONALBERATER-JOBS
   
   27.514 freie Stellen


 * KLINISCHER MONITOR-JOBS
   
   15.912 freie Stellen


 * KLINISCHER SPEZIALIST-JOBS
   
   31.202 freie Stellen


 * KLINISCHE FORSCHUNG-JOBS
   
   96.286 freie Stellen


 * BERATER-JOBS
   
   298.862 freie Stellen


 * ASSOCIATE PRODUCT MANAGER-JOBS
   
   117.842 freie Stellen


 * PLANER-JOBS
   
   42.458 freie Stellen


 * AUTOR-JOBS
   
   32.916 freie Stellen


 * FACHEXPERTE-JOBS
   
   849.142 freie Stellen


 * WISSENSCHAFTLER-JOBS
   
   59.545 freie Stellen


 * SENIOR-JOBS
   
   1.142.468 freie Stellen


 * PRODUKTGRUPPENMANAGER-JOBS
   
   30.173 freie Stellen


 * VERTRIEBSMANAGER-JOBS
   
   348.591 freie Stellen


 * IT-LEITER-JOBS
   
   3.551 freie Stellen


 * PARTNER-JOBS
   
   1.094.512 freie Stellen


 * VERWALTUNGSMANAGER-JOBS
   
   153.611 freie Stellen


 * ADMINISTRATOR-JOBS
   
   476.673 freie Stellen

Weitere ähnliche Jobs anzeigen Weniger ähnliche Jobs anzeigen
Weitere Suchen Weitere Suchen
 *  * Lebensmittelspezialist-Jobs
    * Führungskraft im Finanzwesen-Jobs
    * Leiter-Jobs
    * Leiter Forschung-Jobs
   
    * Director-Jobs
    * Strategieplaner-Jobs
    * Chefredakteur-Jobs
    * Stratege-Jobs
   
    * Wissenschaftler-Jobs
    * Immobilienberater-Jobs

 * LinkedIn © 2024
 * Info
 * Barrierefreiheit
 * Nutzervereinbarung
 * Datenschutzrichtlinie
   
 * Cookie-Richtlinie
 * Copyright-Richtlinie
 * Markenrichtlinine
 * Einstellungen für Nichtmitglieder
 * Community-Richtlinien
   
 *  * العربية (Arabisch)
    * Čeština (Tschechisch)
    * Dansk (Dänisch)
    * Deutsch
    * English (Englisch)
    * Español (Spanisch)
    * Français (Französisch)
    * हिंदी (Hindi)
    * Bahasa Indonesia (Indonesisch)
    * Italiano (Italienisch)
    * 日本語 (Japanisch)
    * 한국어 (Koreanisch)
    * Bahasa Malaysia (Malaysisch)
    * Nederlands (Niederländisch)
    * Norsk (Norwegisch)
    * Polski (Polnisch)
    * Português (Portugiesisch)
    * Română (Rumänisch)
    * Русский (Russisch)
    * Svenska (Schwedisch)
    * ภาษาไทย (Thai)
    * Tagalog (Tagalog)
    * Türkçe (Türkisch)
    * Українська (Ukrainisch)
    * 简体中文 (Chinesisch vereinfacht)
    * 正體中文 (Chinesisch traditionell)
      
   
   Sprache

Zustimmen und LinkedIn beitreten

Durch Klicken auf „Weiter“ stimmen Sie der Nutzervereinbarung, der
Datenschutzrichtlinie und der Cookie-Richtlinie von LinkedIn zu.




Melden Sie sich an, um zu sehen, wen Sie bereits bei BioPharma APAC kennen.
Jetzt anmelden Einloggen


LOGGEN SIE SICH EIN, UM ZU SEHEN, WEN SIE BEREITS BEI BIOPHARMA APAC KENNEN.

Einloggen


SCHÖN, DASS SIE WIEDER DA SIND

E-Mail-Adresse/Telefon




Passwort
Einblenden



Passwort vergessen? Einloggen

oder

Durch Klicken auf „Weiter“ stimmen Sie der Nutzervereinbarung, der
Datenschutzrichtlinie und der Cookie-Richtlinie von LinkedIn zu.



Neu bei LinkedIn? Mitglied werden

oder

Durch Klicken auf „Weiter“ stimmen Sie der Nutzervereinbarung, der
Datenschutzrichtlinie und der Cookie-Richtlinie von LinkedIn zu.



Neu bei LinkedIn? Mitglied werden